Direct oral anticoagulants (DOACs) are prescribed for conditions such as stroke, but they are associated with bleeding complications.

A study investigated the association between polymorphisms in fibrinogen genes and bleeding risk in patients who received DOACs in South Korea. The study found that 2 genotypes were related to bleeding risk for DOACs and developed a risk scoring system to predict it.

^{Illustration by Xinyu Li}